QuVa Pharma, Inc. recalls

All QuVa Pharma, Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (5).

5 recalls published between April 2, 2025 and July 15, 2026. Most common issues: sterility (3).

• Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL… recall
  FDA July 15, 2026 · QuVa Pharma, Inc. · Class II
• R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl… recall
  FDA November 5, 2025 · QuVa Pharma, Inc. · Class II
• fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200… recall
  FDA April 2, 2025 · QuVa Pharma, Inc. · Class II
• fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125… recall
  FDA April 2, 2025 · QuVa Pharma, Inc. · Class II
• fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100… recall
  FDA April 2, 2025 · QuVa Pharma, Inc. · Class II